Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumar Sukhdeo

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2007
Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myelomaKumar Sukhdeo, Mala Mani, Yunyu Zhang, et al.
The Journal of Experimental Medicine|December 11, 2013
Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17AFiorenza Lotti, Awad M Jarrar, Rish K Pai, et al.
Plos One|January 12, 2013
Multiplex flow cytometry barcoding and antibody arrays identify surface antigen profiles of primary and metastatic colon cancer cell linesKumar Sukhdeo, Rosanto I Paramban, Jason G Vidal, et al.
Cancer Cell|April 10, 2007
The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesisDaniel R Carrasco, Kumar Sukhdeo, Marina Protopopova, et al.
Cancer Cell|May 16, 2006
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humansDaniel R Carrasco, Tim Fenton, Kumar Sukhdeo, et al.
Science Translational Medicine|August 24, 2012
Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signalingKohichi Takada, Di Zhu, Gregory H Bird, et al.
Cancer Cell|April 18, 2006
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patientsDaniel R Carrasco, Giovanni Tonon, Yongsheng Huang, et al.
Blood Advances|January 4, 2018
Constitutive Ras signaling and <i>Ink4a/Arf</i> inactivation cooperate during the development of B-ALL in miceTomasz Sewastianik, Meng Jiang, Kumar Sukhdeo, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2007
Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myelomaKumar Sukhdeo, Mala Mani, Yunyu Zhang, et al.
The Journal of Experimental Medicine|December 11, 2013
Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17AFiorenza Lotti, Awad M Jarrar, Rish K Pai, et al.
Plos One|January 12, 2013
Multiplex flow cytometry barcoding and antibody arrays identify surface antigen profiles of primary and metastatic colon cancer cell linesKumar Sukhdeo, Rosanto I Paramban, Jason G Vidal, et al.
Cancer Cell|April 10, 2007
The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesisDaniel R Carrasco, Kumar Sukhdeo, Marina Protopopova, et al.
Cancer Cell|May 16, 2006
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humansDaniel R Carrasco, Tim Fenton, Kumar Sukhdeo, et al.
Science Translational Medicine|August 24, 2012
Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signalingKohichi Takada, Di Zhu, Gregory H Bird, et al.
Cancer Cell|April 18, 2006
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patientsDaniel R Carrasco, Giovanni Tonon, Yongsheng Huang, et al.
Blood Advances|January 4, 2018
Constitutive Ras signaling and <i>Ink4a/Arf</i> inactivation cooperate during the development of B-ALL in miceTomasz Sewastianik, Meng Jiang, Kumar Sukhdeo, et al.
Pageof 3